ScoreWhy is Nutex Health, Inc. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.18 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 253.30%
3
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD 272.68 MM
- NET PROFIT(Q) At USD 46.81 MM has Grown at 164.49%
- CASH AND EQV(HY) Highest at USD 396.51 MM
4
With ROE of 54.75%, it has a fair valuation with a 1.98 Price to Book Value
- Over the past year, while the stock has generated a return of 26.00%, its profits have risen by 75.7% ; the PEG ratio of the company is 0.1
5
High Institutional Holdings at 47.27%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.26% over the previous quarter.
6
Consistent Returns over the last 3 years
- Along with generating 26.00% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nutex Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nutex Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nutex Health, Inc.
26.0%
24.68
94.08%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
253.30%
EBIT Growth (5y)
140.41%
EBIT to Interest (avg)
3.68
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
2.46
Tax Ratio
18.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.27%
ROCE (avg)
65.61%
ROE (avg)
55.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.98
EV to EBIT
1.89
EV to EBITDA
1.76
EV to Capital Employed
2.65
EV to Sales
0.59
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
140.59%
ROE (Latest)
54.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 272.68 MM
NET PROFIT(Q)
At USD 46.81 MM has Grown at 164.49%
CASH AND EQV(HY)
Highest at USD 396.51 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 39.98 %
-7What is not working for the Company
NET SALES(HY)
At USD 368.16 MM has Grown at -21.57%
NET PROFIT(HY)
At USD 58.64 MM has Grown at -29.61%
RAW MATERIAL COST(Y)
Grown by 24.62% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.73 times
Here's what is working for Nutex Health, Inc.
Net Profit
At USD 46.81 MM has Grown at 164.49%
over average net sales of the previous four periods of USD 17.7 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 272.68 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 396.51 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 39.98 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Depreciation
Highest at USD 5.49 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Nutex Health, Inc.
Net Sales
At USD 368.16 MM has Grown at -21.57%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Debtors Turnover Ratio
Lowest at 2.73 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 24.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
